Regarding the PD1/PDL1 immune checkpoint, PDL1 overexpression has been reported in PDA tumors, both in tumor cells and in the scarce immune infiltrates [38,56], and increased PDL1 expression is associated with poor survival [38]. Here, CD274 is linked to Patent ductus arteriosus.